Advancements in Protein Analysis with Leo™ System
Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the life sciences sector, has recently unveiled the enhanced Leo™ System, showcasing its commitment to innovating protein analysis. This state-of-the-art system integrates dual-channel fluorescence detection with chemiluminescence, providing the potential for expanded multiplexing capabilities which are essential for modern research.
Enhanced Detection Technologies
The evolution of the Leo System empowers researchers to analyze up to 24 targets per sample. By supporting complex assay configurations, the system enhances the understanding of protein interactions and functions, which is crucial for both academic and clinical research. This advancement is set to strengthen Bio-Techne's leadership role in the proteomic analytical instrument space.
Fluorescence Detection Capabilities
One of the standout features of the enhanced Leo System is the introduction of dual-channel fluorescence detection. This technology enables scientists to gather richer data from their samples, allowing greater insights into biological processes. By incorporating fluorescence, the system presents a fourth multiplexing option alongside the established molecular weight separation and RePlex capacities.
Streamlined Research Processes
Bio-Techne's new system is designed with efficiency at its core. Researchers can process up to 100 capillaries in just three hours, significantly accelerating workflow and discovery timelines. The ability to multiplex targets with distinct expression levels in a single run translates to faster results and less sample consumption, which is invaluable in research where resources are often limited.
Feedback from Industry Experts
Industry experts have already praised the enhanced Leo System for its high-throughput capabilities. Dr. Alexandre Lucas from the We-Met research group emphasized its impressive precision, noting a minimal variance of only 5–6%. Such consistency is vital when conducting clinical research where accuracy can have significant ramifications.
Driving Innovations in Life Sciences
Will Geist, President of the Protein Sciences Segment at Bio-Techne, highlighted that the next-generation Leo System sets a new benchmark in protein analysis technology. With its advanced detection methods and built-in compliance features adhering to 21 CFR Part 11, researchers can trust that the results obtained are not only quick but also reliable. This technology holds immense potential for energizing the pace at which discoveries in life sciences are made.
Explore the Future of Protein Analysis
For those interested in learning more about the Leo System and its capabilities, a visit to Bio-Techne's official website reveals in-depth functionality and application details. As the life sciences industry continues to evolve, innovations like the Leo System play a pivotal role in shaping the future of research.
About Bio-Techne Corporation
Bio-Techne Corporation (NASDAQ: TECH) stands out as a global life sciences company dedicated to creating advanced tools and reagents that propel scientific discovery. With an extensive product portfolio that supports research into biological processes and diagnostics, Bio-Techne has positioned itself at the forefront of the life sciences industry. The company has achieved remarkable financial success, boasting over $1.2 billion in net sales and employing around 3,100 people worldwide.
Frequently Asked Questions
What is the main feature of the enhanced Leo System?
The enhanced Leo System integrates dual-channel fluorescence detection with chemiluminescence, expanding multiplexing capabilities for protein analysis.
How does the Leo System improve research efficiency?
It allows the processing of up to 100 capillaries in three hours, significantly speeding up the workflow for researchers.
What are the benefits of multiplexing in protein analysis?
Multiplexing enables the simultaneous quantification of multiple targets, enhancing data collection and reducing sample use in experiments.
How does Bio-Techne support compliance in its products?
The Leo System is designed to meet 21 CFR Part 11 compliance, ensuring reliable and regulated analysis results.
Where can I find more information about Bio-Techne?
Further details can be found on Bio-Techne's official website, where they provide extensive information about their products and services.
